DOUBLE-STRANDED MOLECULE INHIBITING THE EXPRESSION OF GPC3
OA: closed
Abstract
The invention features an isolated double-stranded molecule inhibiting a growth of GPC3 expressing cell. The invention also features a method for treating GPC3-related disease including esophageal cancer, gastric cancer, hepatic cancer, osteosarcoma, soft tissue cancer or endometriosis by administering the double-stranded molecule against a GPC3 gene. Furthermore, the invention features products, including the double-stranded molecules and vectors encoding them, as well as compositions containing the molecules or vectors, useful in the provided methods.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-08T06:14:57.058073+00:00